These effects likely occur because DMAA is structurally similar to amphetamine and as a result, the compound is not only a vasoconstricting agent but is also a central nervous system (CNS) stimulant.
Lezi zimo kungenzeka ukuthi zenzeke ngoba i-DMAA ihlelekile ngokufana ne-amphetamine futhi ngenxa yalokho, i-compound ayiyona nje i-agent ye-vasoconstricting kodwa futhi iyisistimu ye-nervous central (CNS) evuselelayo.